The University of Rochester (UR) has a long and extraordinarily rich history of providing first-rate clinical services
to persons with Intellectual and Developmental Disabilities (IDD), and in driving new discoveries through
research that create increased opportunity for individuals with IDD to live their lives to the fullest of their potential.
This proposed UR-IDDRC is founded upon a revolutionary philosophy of medicine, first introduced here at UR
Medical Center by Profs. George Engel and Jon Romano in 1977: The Biopsychosocial Model. This simple,
yet profound idea, that the person seeking treatment is not merely a product of their biology, but rather, is also
an amalgam of their psychology and socio-economic circumstances, places the whole person in all their
complexity at the center of medicine. If ever there was a population that deserves to be recognized and treated
in this holistic humanistic manner, it is those with an IDD. This UR-IDDRC places persons with IDD at the center
of our inclusive neurodiverse mission, and commits to providing excellence in our basic, translational and clinical
research, with a singular focus on providing tractable clinical solutions for these individuals. In the pages of this
program application, we describe the Center’s crucial scientific infrastructure, which supports four cutting-edge
Cores that elevate and accelerate the work of our 105 UR-IDDRC investigators, providing the very latest
available technologies and expertise with high efficiency and excellent cost-effectiveness. These Cores are:
Human Phenotyping & Recruitment (HPR); Translational Neuroimaging & Neurophysiology (TNN); Cell &
Molecular Imaging (CMI); and Animal Behavior and Neurophysiology (ABN). Through vigorous leadership and
in close consultation with our UR-IDDRC community and the five key advisory committees that provide counsel
to our Administrative Core (ADM), we articulate a set of five research foci that embrace key and established
research strengths at our institution while also seeking to expand our program into important areas of concern
to the larger IDD community. These are: (1) Rare and orphaned diseases of neurodevelopment; (2) Parental
stress and early life exposure as determinants of brain development; (3) Neuroinflammatory mechanisms in
pathological brain development; (4) Autism spectrum disorder; (5) Multisensory and sensorimotor integration.
Some 202 ongoing IDD projects, and 9 associated training grants, are supported by this infrastructure, and the
Center Leadership is committed to further growing this already thriving program by attracting and training new
young investigators and clinicians in IDD research. Major efforts to disseminate the work of the Center through
media outlets and culturally competent multilingual publications, oriented at our community, are in place.
Outreach to our IDD community and the public at large is a central concern of the UR-IDDRC. Leveraging the
enormous financial commitment of the University of Rochester’s leadership to developing the UR-IDDRC, and
through a philanthropy-driven annual pilot grant fund of $400,000, UR-IDDRC leadership is strongly positioned
to prosecute an innovative transformative IDD research agenda over the proposed five-year term of this program.
Public Health Relevance Statement
PROJECT NARRATIVE
This new University of Rochester IDDRC establishes the essential scientific Core infrastructure and
administrative architecture to cohere the exceptional talents of 105 IDD investigators around five highly
interlinked research cluster thematic foci, and articulates a clear purpose for our coordinated efforts – to serve
persons with IDD to the best of our abilities, placing their interests at the heart of our research enterprise. Through
a concerted effort across basic, translational and clinical investigators, we have set ourselves the clear goal of
providing actionable clinical solutions for our IDD community. We will partner with our IDD community to
communicate our work, and our passion, in a manner that is culturally competent, inclusive, and publically
oriented.
Eunice Kennedy Shriver National Institute of Child Health and Human Development
CFDA Code
865
DUNS Number
041294109
UEI
F27KDXZMF9Y8
Project Start Date
01-August-2020
Project End Date
31-May-2025
Budget Start Date
01-June-2022
Budget End Date
31-May-2023
Project Funding Information for 2022
Total Funding
$1,228,650
Direct Costs
$909,899
Indirect Costs
$428,651
Year
Funding IC
FY Total Cost by IC
2022
Eunice Kennedy Shriver National Institute of Child Health and Human Development
$1,228,650
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5P50HD103536-03
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5P50HD103536-03
Patents
No Patents information available for 5P50HD103536-03
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5P50HD103536-03
Clinical Studies
No Clinical Studies information available for 5P50HD103536-03
News and More
Related News Releases
No news release information available for 5P50HD103536-03
History
No Historical information available for 5P50HD103536-03
Similar Projects
No Similar Projects information available for 5P50HD103536-03